Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 3;34(2):354-360.
doi: 10.1093/eurpub/ckad225.

Divergent effects of switching from cytology to HPV-based screening in the Nordic countries

Veli-Matti Partanen  1 , Joakim Dillner  2 , Ameli Tropé  3 , Ágúst Ingi Ágústsson  4 , Stefan Lönnberg  1 , Sirpa Heinävaara  1 , Ahti Anttila  1
Affiliations

Divergent effects of switching from cytology to HPV-based screening in the Nordic countries

Veli-Matti Partanen et al. Eur J Public Health. .

Abstract

Background: Cervical cytology has been the primary method of cervical cancer screening for decades. Tests that detect viral HPV are shown in several randomized trials to provide better protection against cancer compared with cytology. HPV-based screening has been implemented alongside cytology in the Nordic countries for several years. The aim of this study was to compare cytology and HPV-based screening in the colposcopy referrals and detection rates of cervical lesions.

Methods: Individual-level screening data from Finland, Iceland, Norway and Sweden were harmonized and aggregated locally. We utilized data for tests taken during years 2015-17 and biopsies taken during years 2015-19 to allow 24 months of follow-up. Age-standardized estimates and age-adjusted risk ratios for six different outcomes of screening management were calculated.

Results: The age-standardized colposcopy rates were higher in HPV-based testing compared with cytology in Finland (3.5% vs. 0.9%) and Norway (6.0% vs. 4.1%) but lower in Sweden (3.7% vs. 4.9%). The relative detection rate of cervical intraepithelial neoplasia grade 2 and above in HPV-based testing compared with cytology was highest in Finland (RR 2.37, 95% CI 2.13-2.63) and Norway (RR 1.66, 95% CI 1.57-1.72) while in Sweden the difference was not statistically significant (RR 0.98, 95% CI 0.95-1.00).

Conclusions: The effects of implementing HPV screening varied by country as different screening algorithms were implemented. HPV-based screening increases colposcopy rates mainly through referrals from increased repeat testing and detection rate is therefore significantly higher compared with cytology. Monitoring of these indicators in subsequent rounds of HPV-based screening remains essential.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age-adjusted RRs for different outcomes in HPV testing compared with cytology in 30- to 64-year-old women in 2015–17.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. - PubMed
    1. World Health Organization (WHO). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva: World Health Organization, 2020.
    1. Anttila A, Pukkala E, Söderman B, et al.Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence. Int J Cancer 1999;83:59–65. - PubMed
    1. Kyndi M, Frederiksen K, Krüger Kjaer S.. Cervical cancer incidence in Denmark over six decades (1943-2002). Acta Obstet Gynecol Scand 2006;85:106–11. - PubMed
    1. Lönnberg S, Hansen BT, Haldorsen T, et al.Cervical cancer prevented by screening: long-term incidence trends by morphology in Norway. Int J Cancer 2015;137:1758–64. - PubMed

MeSH terms

Grants and funding